Fortunes at the top of the global wealth ladder are shifting in real time, mirroring volatility across equities, commodities, and currencies. The latest data from
Neurocrine Biosciences has agreed to acquire Soleno Therapeutics in a $2.9 billion all-cash transaction, reinforcing its strategic expansion into endocrinology and rare disease treatments. Under
The Eli Lilly and Company is accelerating its push into artificial intelligence with a deal worth up to $2.75 billion with Insilico Medicine, signaling a
Exscape Group today announced a strategic partnership with Buckeye Landscape Service, marking a significant milestone in the company’s continued expansion across the Columbus metropolitan area.
For most drivers, the Alpine driving season begins late — often only in May or even June, when the highest passes finally reopen. But for
Shamekh SIV Solutions, LLC announced their $5.8 billion global plan for a series of pharmaceutical manufacturing facilities aligned with the executive order signed by President Trump on May
Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with
On June 15, Boston—one of the world’s leading biotechnology hubs—will host the Global BIOCHINA Forum. This exclusive event provides a unique platform for industry leaders,
On the second day of an official visit to France, His Excellency Fahad Abdulrahman AlJalajel, Minister of Health of the Kingdom of Saudi Arabia, held bilateral meetings with
Labcorp, a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio with two solutions: Labcorp Plasma Detect for clinical
